Gurrola SA, Huerta LJG

Idioma: Español
Referencias bibliográficas: 24
Paginas: 77-86
Archivo PDF: 331.93 Kb.

RESUMEN

En este articulo se pretende abarcar los aspectos más importantes de la historia del asma, desde sus registros más antiguos hasta las nuevas propuestas de tratamiento, pasando por las antiguas civilizaciones, el descubrimiento de la entidad y su fisiopatología, los pioneros en el campo del tratamiento farmacológico y los retos más actuales.

REFERENCIAS (EN ESTE ARTÍCULO)

1. Murtagh P. Asma: ayer y hoy. Arch Argent Pediatr 2009; 107(2): 146-151.

2. Cohen S. Asthma in antiquity, the ebers papyrus. Allergy Proc 1992; 13(3): 147-154.

3. Ebbell B. The Papyrus Ebers. The greatest Egyptian medical document. Copenhagen: Levin and Munksgaard, 1937.

4. Estes JW. The medical skills of ancient Egypt. In: Canton MA. Science history publishers. 1989: 92-118, 139-157.

5. Cromptom G. A brief history of inhaled asthma therapy over the last fi fty years. Primary Care Respiratory Journal 2006; 2(15): 326-331.

6. Walter M. A Centennial History of Research on Asthma Pathogenesis. American Journal of Respiratory Cel and Molecular Biology 2005; (32): 483-489.

7. Reed CE. The pathogenesis of asthma. Med Clin North Am 1974; 58: 55-63.

8. Persson CG. On the medical history of xanthines and other remedies for asthma: a tribute to HH Salter. Thorax 1985; 40: 881-886.

9. Partridge M. Asthma 1987-2007. What have we achieved and what are the persisting challenges? Primary Care Respiratory Journal 2007; 2(16): 145-14.

10. Expert Panel Report 3, Guidelines for the diagnosis and managemente of asthma, full report 2007; http://www.nhlbi.nih.gov

11. McFadden. A century of asthma, American Journal Of Respiratory And Critical Care Medicine 2005; 171: 215-221.

12. Chu E. Asthma a hundred years of treatment and onward. American Journal of Respiratory and Critical Care Medicine 2005; 171: 1202-1208.

13. Sanders M. Inhalation therapy, an historical review. Primary Care Respiratory Journal 2007; 2(16): 71-81.

14. Fitzgerald M. et al. The global strategy for asthma management and prevention (GINA)http://www.ginasthma.org; 2010.

15. Anderson P. History of aerosol therapy. Liquid nebulizations to MDIs to DPIs. Respiratory Care 2005; 50(9): 1139-1150.

16. Persson C. On the medical history of xanthines and other remedies for asthma: a tribute to HH Salter. Thorax 1985; 40: 881-886.

17. Levy M. The UK general practice airway group, its formation, development and influence on the management of asthma and other respiratory diseases over the last twenty years. Primary Care Respiratory Journal 2007; 16(3): 132-139.

18. Hart L, Lim S, Adcock I, Barnes PJ, Chung KF. Effects of inhaled corticosteroid therapy on expression and DNA-binding activity of nuclear factor-_B in asthma. Am J Respir Crit Care Med 2000; 161: 224-231.

19. Castro M, Bloch SR, Jenkerson MV, DeMartino S, Hamilos DL, Cochran RB et al. Asthma exacerbations after glucocorticoid with drawal refl ects T cell recruitment to the airway. Am J Respir Crit Care Med 2004; 169: 842-849.

20. Mosmann TR, Cherwinski H, Bond MW, Giedlin MA, Coffman RL. Two types of murine helper T cell clone: I. Defi nition according to profi les of lymphokine activities and secreted proteins. J Immunol 1986; 136: 2348-2357.

21. Rossenwasser L. Incorporating Omalizumab ento asthma treatment guidelines: Consensus panel recommendations. P&T 2003; 6(28): 400-413.

22. Ring J, Gutermuth J. 100 years of hyposensitization history of allergen-specifi c immunotherapy (ASIT). Allergy 2011; 66: 713-724.

23. Gozde K et al. Specific immunotherapy improves asthma related quality of life in childhood. Allergol Immunopathol (Madr) 2011; 39(2): 68-72.

24. Pérez E y cols. Informe de la OMS. Inmunoterapia con alergenos: Vacunas terapéuticas para las enfermedades alérgicas, 1999: 1-48.